There Won’t Be a THC Limit for Driving in California
Blood tests are inherently flawed, research has shown, because they don’t indicate how long the THC has been in the system, the driver’s tolerance, how high they actually are or whether they are impaired at that moment.
CT Scans Reveal Higher Rates of Emphysema in Cannabis Smokers
Cannabis smokers experience emphysema at higher rates than both non-smokers and tobacco smokers, according to new research from the Ottawa Hospital.
Cannabis Legalization Associated with Increase in Driving Accidents
This “small but significant increase” in fatal motor vehicle accidents and fatalities could be curbed by effective regulations and educational campaigns, according to researchers.
Virginia Legalizes Recreational Cannabis
The governor of Virginia has signed the state’s recreational cannabis bill, effectively legalizing marijuana possession from July 1, 2021.
New Mexico Legalizes Recreational Cannabis
During a legislative session on March 31, the state House and Senate both passed a legalization bill and a cannabis criminal record expungement bill.
New York Legalizes Recreational Cannabis
Lawmakers in New York have voted to legalize an adult-use cannabis market across the state.
AOAC Opens Call for Toxin Screening Methods in Cannabis Materials
AOAC International is now inviting submissions from cannabis laboratories with unique methods for mycotoxin screening and for the detection of Shiga toxin-producing Escherichia coli in cannabis plant materials and derivatives.
More Evidence Needed to Support Medical Cannabis Use for Pain, Say Experts
The International Association for the Study of Pain says it cannot currently endorse the general use of cannabis and cannabinoids for pain relief based on a lack of high-quality evidence.
FDA Issues Warning Letters to Two Companies Selling CBD Products for Pain Relief
California’s Honest Globe, Inc. and Michigan’s BioLyte Laboratories, LLC, have become the latest in a long line of companies to receive official warning letters from the FDA for the illegal marketing of unapproved CBD-containing drugs.
